CYP1A1 and benign prostatic hyperplasia: Likewise, prostate cancer tissues have lower CYP1A1 methylation in region C in comparison with BPH samples (18.0 ± 2.3% and 40.7 ± 4.2%, respectively; P < 0.001, Figure 3B).